CliffBio

CSL Behring

Patent cliffs & loss of exclusivity

CSL Behring is a biotechnology company developing biotherapies for the treatment of life-threatening medical conditions.

Company

AngelList URLhttps://angel.co/company/csl-behring
Business ModelCommerce
Legal NameCSL Behring LLC
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/csl-behring
Facebook URLhttps://www.facebook.com/CSL-Behring-51976781570/
Fax Number+1 610-878-4009
Full Address1020 First Avenue King of Prussia, PA 19406-0901 USA

8 upcoming patent cliffs

DrugIngredientTypeCliff
  1. AlburxAlbumin (Human)BiologicJul 1988
  2. AlburxAlbumin (Human)BiologicJul 1988
  3. AlburxAlbumin (Human)BiologicJul 1988
  4. AlburxAlbumin (Human)BiologicJul 1988
  5. Humate-PAntihemophilic Factor/von Willebrand Factor Complex (Human)BiologicApr 2012
  6. Humate-PAntihemophilic Factor/von Willebrand Factor Complex (Human)BiologicApr 2012
  7. Humate-PAntihemophilic Factor/von Willebrand Factor Complex (Human)BiologicApr 2012
  8. ZemairaAlpha-1-Proteinase Inhibitor (Human)BiologicJul 2015
  9. RhophylacRho(D) Immune Globulin Intravenous (Human)BiologicFeb 2016
  10. RhophylacRho(D) Immune Globulin Intravenous (Human)BiologicFeb 2016
  11. PrivigenImmune Globulin Intravenous (Human), 10% LiquidBiologicJul 2019
  12. PrivigenImmune Globulin Intravenous (Human), 10% LiquidBiologicJul 2019
  13. PrivigenImmune Globulin Intravenous (Human), 10% LiquidBiologicJul 2019
  14. RiastapFibrinogen Concentrate (Human)BiologicJan 2021
  15. PrivigenImmune Globulin Intravenous (Human), 10% LiquidBiologicOct 2021
  16. BerinertC1 Esterase Inhibitor (Human)BiologicOct 2021
  17. HizentraImmune Globulin Subcutaneous (Human), 20% LiquidBiologicMar 2022
  18. HizentraImmune Globulin Subcutaneous (Human), 20% LiquidBiologicMar 2022
  19. HizentraImmune Globulin Subcutaneous (Human), 20% LiquidBiologicMar 2022
  20. HizentraImmune Globulin Subcutaneous (Human), 20% LiquidBiologicMar 2022
  21. CorifactFactor XIII Concentrate (Human)BiologicFeb 2023
  22. PrivigenImmune Globulin Intravenous (Human), 10% LiquidBiologicFeb 2025
  23. KcentraProthrombin Complex Concentrate (Human)BiologicApr 2025
  24. KcentraProthrombin Complex Concentrate (Human)BiologicNov 2025
  25. HaegardaC1 Esterase Inhibitor Subcutaneous (Human)BiologicJun 2029
  26. HaegardaC1 Esterase Inhibitor Subcutaneous (Human)BiologicJun 2029
  27. ZemairaAlpha-1-Proteinase Inhibitor (Human)BiologicApr 2031
  28. ZemairaAlpha-1-Proteinase Inhibitor (Human)BiologicApr 2031
  29. Hemgenixetranacogene dezaparvovec-drlbBiologicNov 2034
  30. HizentraImmune Globulin Subcutaneous (Human), 20% LiquidBiologicApr 2035
  31. Andembrygaradacimab-gxiiBiologicJun 2037
  32. Andembrygaradacimab-gxiiBiologicJun 2037

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Not found